X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Indoco Remedies with IL&FS INV. MANAGERS - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs IL&FS INV. MANAGERS - Comparison Results

INDOCO REMEDIES    Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

IL&FS INV. MANAGERS 
   Change

IL&FS Investment Managers Limited (IIML) is a subsidiary of Infrastructure Leasing & Financial Services Limited (IL&FS). It was founded as Credit Capital Venture Fund (CCVF) in 1989, as an affiliate of Lazard Brothers. It was then later acquired by I... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES IL&FS INV. MANAGERS INDOCO REMEDIES/
IL&FS INV. MANAGERS
 
P/E (TTM) x 31.0 28.3 109.5% View Chart
P/BV x 3.7 1.7 222.9% View Chart
Dividend Yield % 0.6 5.7 10.7%  

Financials

 INDOCO REMEDIES   IL&FS INV. MANAGERS
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-17
IL&FS INV. MANAGERS
Mar-16
INDOCO REMEDIES/
IL&FS INV. MANAGERS
5-Yr Chart
Click to enlarge
High Rs36024 1,533.6%   
Low Rs24915 1,628.1%   
Sales per share (Unadj.) Rs119.05.8 2,044.9%  
Earnings per share (Unadj.) Rs8.41.8 468.3%  
Cash flow per share (Unadj.) Rs15.22.4 625.1%  
Dividends per share (Unadj.) Rs1.601.20 133.3%  
Dividend yield (eoy) %0.56.2 8.5%  
Book value per share (Unadj.) Rs70.712.6 559.8%  
Shares outstanding (eoy) m92.15314.03 29.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.63.3 76.8%   
Avg P/E ratio x36.410.9 335.4%  
P/CF ratio (eoy) x20.08.0 251.3%  
Price / Book Value ratio x4.31.5 280.6%  
Dividend payout %19.167.2 28.5%   
Avg Mkt Cap Rs m28,0836,092 461.0%   
No. of employees `0006.0NA 13,718.2%   
Total wages/salary Rs m2,167515 420.7%   
Avg. sales/employee Rs Th1,817.041,540.0 4.4%   
Avg. wages/employee Rs Th359.011,704.5 3.1%   
Avg. net profit/employee Rs Th127.712,745.9 1.0%   
INCOME DATA
Net Sales Rs m10,9681,828 600.1%  
Other income Rs m4080 49.7%   
Total revenues Rs m11,0071,908 577.0%   
Gross profit Rs m1,565872 179.4%  
Depreciation Rs m633204 309.7%   
Interest Rs m620-   
Profit before tax Rs m909748 121.6%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m139187 74.3%   
Profit after tax Rs m771561 137.4%  
Gross profit margin %14.347.7 29.9%  
Effective tax rate %15.325.0 61.1%   
Net profit margin %7.030.7 22.9%  
BALANCE SHEET DATA
Current assets Rs m5,7253,042 188.2%   
Current liabilities Rs m5,454718 759.3%   
Net working cap to sales %2.5127.1 1.9%  
Current ratio x1.04.2 24.8%  
Inventory Days Days620-  
Debtors Days Days72163 44.0%  
Net fixed assets Rs m5,3071,338 396.8%   
Share capital Rs m184628 29.3%   
"Free" reserves Rs m6,3312,624 241.3%   
Net worth Rs m6,5163,967 164.3%   
Long term debt Rs m1,3230-   
Total assets Rs m11,9704,791 249.9%  
Interest coverage x15.6NM-  
Debt to equity ratio x0.20-  
Sales to assets ratio x0.90.4 240.2%   
Return on assets %7.011.7 59.4%  
Return on equity %11.814.1 83.7%  
Return on capital %12.418.8 65.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,507803 561.4%   
Fx outflow Rs m1,14129 3,882.3%   
Net fx Rs m3,366773 435.2%   
CASH FLOW
From Operations Rs m886921 96.3%  
From Investments Rs m-1,706211 -810.2%  
From Financial Activity Rs m1,316-466 -282.6%  
Net Cashflow Rs m497665 74.6%  

Share Holding

Indian Promoters % 59.2 50.5 117.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 3.7 340.6%  
FIIs % 6.0 0.4 1,500.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 45.4 49.3%  
Shareholders   12,805 31,147 41.1%  
Pledged promoter(s) holding % 0.0 100.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   REDINGTON (INDIA)  IIFL HOLDINGS  GREENPLY IND  TALWALKARS BETTER VAL.  INDIABULLS FIN. SER.  



Today's Market

Sensex Trades in Red; PSU & Energy Stocks Decline(01:30 pm)

Indian share markets continued to trade in red during the noon session weak Asian markets. PSU stocks and energy stocks are witnessing majority of the selling activity.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Feb 22, 2018 03:37 PM

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES - MOTILAL OSWAL COMPARISON

COMPARE INDOCO REMEDIES WITH

MARKET STATS